Hormone Optimizing Warrior M.D.

A respected gynecologist says the O-shot has no biological basis. I think she's wrong, and I can tell you exactly why.

Dr. Jen Gunter has written twice that the O-shot is untested and built on a sketchy past. Both articles are linked below, and I'd encourage you to read them.

Her central claim is that there's no damaged tissue down there to heal, so there's nothing for platelet rich plasma to do. I can name three circumstances that damage those exact tissues, and almost every woman listening has lived through at least one.

Where I don't disagree with her is the missing research. So I'll explain why these studies are so hard to run, what the few that exist actually found, and the one group of women I usually talk out of this procedure entirely.

In this episode you'll learn…

• Why critics argue there's no damaged tissue down there to repair.

• How many women sustain tissue trauma during a first vaginal birth.

• Why the clitoris can be injured during delivery without anyone noticing.

• What portion of women develop skin conditions affecting the vaginal opening.

• Why the vulva has been called the forgotten pelvic organ.

• How menopause damages the same tissues the injection targets.

• Why comparing the injection to surgery misses what actually happens.

• What PRP did for women left with painful scars after surgery.

• Which once standard procedures were abandoned after proper trials.

• Why a convincing placebo for this procedure is nearly impossible.

• Why studies rarely follow the actual trademarked injection protocol.

• What a review of the existing research found about incontinence.

• Why age changes how well the injection is likely to work.

"The troubling backstory behind the 'O shot®'" by Dr. Jen Gunter: https://drjengunter.wordpress.com/2017/11/26/the-troubling-backstory-behind-the-o-shot/

"The O shot is untested with a sketchy past" by Dr. Jen Gunter: https://vajenda.substack.com/p/the-o-shot-is-untested-with-a-sketchy

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

There's an injection that improves orgasms and urinary leaking at the same time, and almost no woman has heard of it.

The O-shot involves no estrogen and no hormones. It's made from your own blood, drawn from your arm, and spun down before it goes anywhere. The needle is the same one we use for Botox.

It was designed around sexual function, and it delivers on that. But something else kept happening to the women who had it done, something nobody was aiming for, and that's become one of the main reasons I've come to recommend it.

In this episode you'll learn…

• What the O-shot injects and where the two injections go.

• Why the injection hurts far less than most women expect.

• What platelet rich plasma is and when the term first appeared.

• How researchers discovered that platelets could stimulate tissue repair.

• What separates platelet rich plasma from platelet rich fibrin.

• Why PRP already appears in microneedling, hair restoration, and orthopedics.

• What gynecologists have been treating with PRP beyond sexual function.

• Why insurance companies label these gynecological applications as experimental.

• What a review of the published PRP research actually found.

• Who coined the term O-shot and trains providers to perform it.

• What a provider should feel immediately after injecting the G-spot.

• What the Skene's glands are and where they sit.

• How those glands help stop bacteria from reaching the urethra.

• Why nourishing erectile tissue changes arousal and orgasm quality.

• How long improvements in urinary leaking tend to last.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

Every vaginal estrogen product treats the inside. Only one of them treats the outside.

Last week, I made the case that vaginal estrogen does not stay where you put it. This week, I go through what is actually available, and what each option can and cannot do for you.

We cover the creams, the inserts, the ring, and the one FDA approved product that contains no estrogen at all. One of these treats something none of the others can touch, which is why I keep prescribing it despite the mess.

I also get into compounded formulations and read the ingredient list on a common estradiol cream so you can hear what you are really putting in your body.

In this episode you'll learn…

• Which three vaginal estrogen options carry FDA approval in the United States.

• Why the cream treats external vulvar symptoms the other options cannot.

• What makes cream dosing less precise than inserts and rings.

• Why conjugated equine estrogen cream offers no advantage over estradiol.

• How the softgel insert helps women who struggle with applicators.

• Why stopping inserts for weeks can undo months of symptom control.

• What Estring releases daily and how long it stays in place.

• How four applications a year compare with over one hundred.

• Why the ring suits women who cannot remember twice weekly treatment.

• What conditions make the ring unsafe to insert at all.

• What Intrarosa offers women who cannot use estrogen at all.

• Why daily use turns a local vaginal treatment into whole body therapy.

• How compounded products are regulated despite lacking FDA approval.

• What the ingredient list on a common estradiol cream actually contains.

• Why estriol has recently become popular in the aesthetic world.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

Women have been told for decades that vaginal estrogen stays where you put it, which means no progesterone and nothing to monitor.

I do not believe that is true, and this week I lay out why.

We start with what genitourinary syndrome of menopause, or GSM, actually looks like, including the urinary half of it that almost nobody connects back to hormones. Then I make my case for what happens to the estrogen after it leaves the vaginal tissue, and what two safeguards I think every woman using it should have.

I also share an ultrasound finding that changed how I think about yearly screening, in a patient who was not using hormones at all.

In this episode you'll learn…

• What separates local hormone therapy from whole body hormone therapy.

• What genitourinary syndrome of menopause (GSM) covers beyond vaginal dryness.

• Why dryness comes from estrogen loss rather than from aging.

• How the tissues change without the blood flow estrogen provides.

• Why painful sex often goes unmentioned until a relationship is already threatened.

• Why recurrent urinary infections after 50 are a hallmark of GSM.

• Why medical training has left doctors unprepared to recognize GSM.

• What drives the bladder spasms behind urgency and frequency.

• How pelvic floor treatment compares with thousands of Kegel contractions.

• What common overactive bladder medications carry as long term risks.

• Why the vagina has long been used to deliver medication into the body.

• How absorption from vaginal estrogen varies enormously between women.

• Why some women need progesterone despite using only vaginal estrogen.

• Why blood testing will almost never detect vaginal estradiol.

• Why whole body hormone therapy does not always remove the need for vaginal estrogen.

Check out my article "Why Is Your Bladder Going Crazy After Menopause?": https://mirelacernaianu.substack.com/p/why-is-your-bladder-going-crazy-after-menopause

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

Two of the best alternative options for estradiol come with instructions almost nobody reads.

The patch is not the only thing running short. This week, I continue the series with two more alternatives: one that almost no physician thinks to offer, and one that has quietly become the most requested.

We look at transdermal spray and estradiol gel, how each one is applied, and what those oddly specific application rules exist to prevent. The number printed on the label turns out to have very little to do with how much estradiol actually reaches your bloodstream.

I also explain why one of these products has never once shown me what it's supposed to in my own patients' lab results.

In this episode you'll learn…

• Why transdermal estradiol spray remains unknown to most prescribing physicians.

• How additional daily sprays must be placed to avoid overlapping skin.

• Why three or four sprays daily create hormone surges and crashes.

• What those surges can trigger beyond the symptoms being treated.

• How estradiol transfers to children, pets, and partners after application.

• Why the spray delivers far less estradiol than each dose suggests.

• What FSH testing reveals about how well the spray absorbs.

• Why the spray carries narrower FDA approval than other estradiol options.

• What the spray costs monthly with and without discount programs.

• Why estradiol gel sits at the top of many plan B lists.

• How three FDA approved gel products differ in delivery and dosing.

• Why single dose packets make adjusting the dose easier than pumps.

• What metered dose pumps require before the very first use.

• Why only a small fraction of applied gel reaches circulation.

• What can happen when children are unknowingly exposed to estradiol.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

The patch shortage has a plan B, and most women have never heard of it.

Running out of the estradiol patch is no longer a hypothetical for a lot of women, so I'm starting a series on the FDA approved alternatives worth having ready.

In this episode, we look at the vaginal ring: what it delivers, how long it stays in, and why its bioavailability may surprise you. Two rings sit on the market under similar names (Femring and Estring) for very different purposes, and confusing them is easy.

We also get into why many women say no to this option, when it becomes the wrong choice entirely, and what the manufacturer's savings program actually costs once you read the fine print.

In this episode you'll learn…

• Why the estradiol patch shortage is likely here to stay.

• Why every woman using the patch needs to have a plan B ready.

• How two similarly named vaginal rings serve completely different purposes.

• What separates true menopause hormone therapy from local vaginal estrogen.

• Why the ring contains estradiol acetate instead of bioidentical estradiol.

• How ring bioavailability compares with the patch many women depend on.

• What 90 days of steady release means alongside pellet therapy.

• Why many women choose to turn down the ring despite its convenience.

• How limited dosing restricts adjustments once the ring is placed.

• What discharge, irritation, and yeast infections reveal about microbiome disturbance.

• Why ring position can trigger urinary frequency, urgency, and recurrent infections.

• How years since menopause has began determines whether the ring is appropriate.

• Why some tissue needs priming before the ring becomes comfortable.

• What the ring costs retail and through higher insurance tiers.

• How copay cards can reduce the first prescription but not the refills.

• What makes pellet therapy worth comparing at a similar price point.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

The estradiol patch may be convenient, but getting the right dose is far more complicated than it seems.

Finding the right hormone dose is not as simple as picking a number from a chart. Two women can use the same patch and have completely different results.

In this episode, we get into what happens when the dose that controls symptoms also creates side effects, why switching brands can change hormone absorption, and why the patch shortage is creating a problem that goes far beyond an empty pharmacy shelf.

And just when the patch seems like the easiest solution, another question appears: how do you actually know how much estradiol your body is receiving?

In this episode you'll learn…

• How age and time since menopause influence your starting estradiol patch dose.

• Why women further from menopause may need slower dose increases.

• What can happen when estrogen reaches previously deprived tissues too quickly.

• How personal medical history can limit the available patch dosing options.

• Why perimenopausal women may respond differently to standard patch doses.

• How the same estradiol patch can produce different absorption between women.

• Why skin hydration, thickness, location, products, and sweating affect absorption.

• What hormone testing reveals at different points during patch use.

• How testing midway between patches can provide a useful exposure estimate.

• Why FSH can reveal changes in estradiol absorption between different patch brands.

• How patch shortages can force unexpected changes in treatment plans.

• Why combining multiple lower-dose patches may become necessary due to the shortages.

• What happens when insurance refuses to cover multiple boxes.

• Why only a small number of manufacturers produce patches for America.

• What could happen as demand for hormone therapy continues increasing.

• Why the shortage may continue well beyond the immediate future.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

The most popular estrogen therapy may not work the way you think it does.

The estradiol patch has become a go-to option for menopause therapy, but popularity does not automatically mean every woman gets the same results.

In this episode, we look at what actually happens after the patch goes on and why the timing of estrogen delivery can change the experience completely. A patch that seems like a simple "put it on and forget it" solution turns out to have some important differences depending on how often it is changed.

We also get into why one version can leave women feeling a dip in symptoms before the next application, while another may provide a steadier experience.

In this episode you'll learn…

• How the estradiol patch became the most requested estrogen therapy.

• Why patch popularity has contributed to a nationwide supply shortage.

• What changed after the removal of estrogen's black box warning.

• How patch convenience can improve consistency with hormone therapy.

• Why twice-weekly patches are often preferred over weekly patches.

• What happens when estradiol levels begin dropping before patch replacement.

• How patch size affects comfort, visibility, and skin adhesion.

• Why swimming, sweating, and exercise can influence patch performance.

• What makes estradiol delivery through the skin different from pills.

• How bioavailability affects the amount of hormone reaching tissues.

• What estrogen levels may be needed for different treatment goals.

• How patch dosing ranges provide more flexibility than other options.

• What questions should be answered before choosing a patch dose.

• Why the patch shortage could change which therapy women choose.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

Bioidentical hormones have become one of the biggest debates in menopause medicine...but how much of what you've heard is actually true?

Few topics create more confusion than bioidentical hormone therapy. Some call it the future of menopause care, and others dismiss it outright.

In this episode, I'll cut through decades of conflicting opinions and challenge some of the biggest assumptions surrounding hormone therapy.

If you've ever wondered whether the controversy is driven by science, regulation, marketing, or something else entirely, this episode gives you the context you need to make sense of it all.

In this episode you'll learn…

• What makes a hormone truly bioidentical at the molecular level.

• Why bioidentical and synthetic hormones are not the same thing.

• How the Women's Health Initiative changed menopause care for decades.

• Why hormone receptors may influence treatment effectiveness and safety.

• What hormone therapy actually changes beyond relieving menopause symptoms.

• How bioidentical hormones interact differently with cellular receptors.

• Why many FDA-approved hormone products are already bioidentical.

• What compounded hormone therapy is designed to accomplish.

• How personalized dosing can solve problems that standard products cannot.

• Why "not FDA approved" does not mean unregulated or unsafe.

• How individualized hormone therapy fills gaps left by mass-produced medications.

• Why testosterone therapy still requires compounding for many women.

• What situations make compounded hormone therapy a reasonable option.

• How choosing the right pharmacy becomes part of safe treatment.

• Why bioidentical hormones continue gaining attention in menopause medicine.

• What women should understand before choosing any hormone therapy.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/

Most osteoporosis medications promise protection, but not all of them work the same way.

Some slow bone breakdown, while others help rebuild bone from the inside out. Knowing the difference could completely change how osteoporosis is treated.

In this episode, we take a close look at the medications used for osteoporosis today, why some are reserved for higher-risk cases, and why treatment decisions should never be one-size-fits-all.

We also explore the trade-offs, the timing, and the questions every woman should understand before deciding which path to take.

In this episode you'll learn…

• How osteoporosis medications fall into two completely different treatment categories.

• What bisphosphonates actually do inside the skeleton over time.

• How Prolia and Evenity work differently from traditional osteoporosis medications.

• Why anabolic therapies are changing osteoporosis treatment for high-risk patients.

• How treatment choice depends on fracture risk and bone density.

• Why medication timing can influence long-term osteoporosis outcomes.

• What side effects deserve discussion before starting osteoporosis treatment.

• How rare complications compare with the risks of untreated osteoporosis.

• Why dental health becomes part of osteoporosis medication planning.

• What can happen when osteoporosis medications are stopped too suddenly.

• How follow-up bone density testing can guide future treatment decisions.

• Why medication works best alongside exercise and nutrition strategies.

• What realistic expectations look like during osteoporosis treatment.

• How individualized treatment plans can improve long-term bone health.

Connect with Dr. Cernaianu

https://www.herabeautyandwellness.com/

https://www.instagram.com/herabeautyandwellness/

https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/